PIACERI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 4.272
EU - Europa 2.641
AS - Asia 618
AF - Africa 9
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.544
Nazione #
US - Stati Uniti d'America 4.263
RU - Federazione Russa 871
PL - Polonia 730
IT - Italia 352
IE - Irlanda 274
SE - Svezia 205
CN - Cina 200
SG - Singapore 152
HK - Hong Kong 114
IN - India 66
DE - Germania 55
UA - Ucraina 41
GB - Regno Unito 38
FI - Finlandia 37
JO - Giordania 37
VN - Vietnam 17
KR - Corea 16
ES - Italia 13
TR - Turchia 10
CA - Canada 9
CI - Costa d'Avorio 9
BE - Belgio 8
CH - Svizzera 7
FR - Francia 7
JP - Giappone 5
AR - Argentina 2
NL - Olanda 2
CZ - Repubblica Ceca 1
EU - Europa 1
IR - Iran 1
PE - Perù 1
Totale 7.544
Città #
Warsaw 730
Fairfield 550
Santa Clara 522
Ashburn 506
Chandler 274
Dublin 272
Woodbridge 270
Seattle 254
Houston 253
Cambridge 227
Wilmington 172
Altamura 123
Ann Arbor 122
Lawrence 118
Singapore 117
Dearborn 82
Princeton 78
Hong Kong 64
Moscow 62
Beijing 61
Florence 59
Boston 51
Buffalo 45
Mumbai 42
San Diego 35
Bremen 31
Medford 26
Boardman 24
Pune 23
Shanghai 23
Jacksonville 21
Kent 20
Hefei 15
New York 14
Dong Ket 13
Falls Church 13
Norwalk 13
Seoul 13
Hillsboro 11
Barcelona 10
Izmir 10
West Jordan 10
Abidjan 9
Jinan 9
Los Angeles 9
Brussels 8
London 8
Nanjing 8
Toronto 8
Andover 7
Bern 7
Kunming 7
Redwood City 7
Rome 7
Turin 7
Cagliari 5
Guangzhou 5
Misano Adriatico 5
Phoenix 5
Stia 5
Kilburn 4
Milan 4
Yubileyny 4
Castelfidardo 3
Castelliri 3
Chengdu 3
Ciserano 3
Fuzhou 3
Gorle 3
Helsinki 3
Jamaica 3
Prescot 3
Salerno 3
Santa Maria A Monte 3
Siena 3
Spoltore 3
Zhengzhou 3
Afragola 2
Barletta 2
Bloomsbury 2
Bologna 2
Casamarciano 2
Catania 2
Chiswick 2
Chongqing 2
Cosenza 2
Dallas 2
Genoa 2
Hounslow 2
Jiaxing 2
Livorno 2
Lomas de Zamora 2
Monteforte Irpino 2
Naples 2
New Bedfont 2
Piombino 2
Pontedera 2
Prato 2
Rende 2
Rosarno 2
Totale 5.605
Nome #
Profilo Genetico ed Epigenetico in pazienti con Demenza Frontotemporale 313
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 295
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 255
FDG PET and the genetics of dementia 238
Association Study of Genetic Variants in CDKN2A/CDKN2B genes/Loci with Late-Onset Alzheimer's Disease 221
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 185
A PALB2 germline mutation associated with hereditary breast cancer in Italy. 166
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies 166
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 147
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 145
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 133
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 133
Ataxia-telangiectasia mutated (ATM) genetic variant in Italian centenarians 131
Analyses of the role of the glucocorticoid receptor gene polymorphism (rs41423247) as a potential moderator in the association between childhood overweight, psychopathology, and clinical outcomes in Eating Disorders patients: A 6 years follow up study. 131
Biomarkers study in atypical dementia: proof of a diagnostic work-up 128
Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications. 125
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 123
Primary Progressive Aphasia: Natural History in an Italian Cohort 122
Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation 121
Tumor necrosis factor α influences phenotypic plasticity and promotes epigenetic changes in human basal forebrain cholinergic neuroblasts 116
Association of the Variant Cys139Arg at GRN Gene to the Clinical Spectrum of Frontotemporal Lobar Degeneration 115
Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (Scientific Reports (2017) DOI: 10.1038/s41598-017-09320-z) 114
A case of limbic encephalitis evolving into a frontotemporal dementia-like picture 111
Genetics of familial and sporadic Alzheimer's disease. 110
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 110
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 109
Progranulin genetic screening in frontotemporal lobar degeneration patients from central Italy. 108
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia 108
Crossed aphasia in nonfluent variant of primary progressive aphasia carrying a GRN mutation 103
Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia 103
Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects. 102
DAPK1 is Associated with FTD and not with Alzheimer's Disease 102
Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease 102
Suitability of neuropsychological tests in patients with vascular dementia (VaD). 98
A Pan-European study of theC9orf72Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability and Intermediate Repeats 98
Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease. 95
Genetics of Alzheimer's Disease and Frontotemporal Dementia 95
Genetic Heterogeneity of Alzheimer's Disease: Embracing Research Partnerships 95
Folate, Homocysteine, Vitamin B12, and Polymorphisms of Genes Participating in One-Carbon Metabolism in Late-Onset Alzheimer's Disease Patients and Healthy Controls 94
Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration 90
Heterozygous TREM2 mutations in frontotemporal dementia 88
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 88
Tomm40 polymorphisms in Italian Alzheimer’s disease and frontotemporal dementia patients 88
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 88
Clinical heterogeneity in Italian patients with amyotrophic lateral sclerosis 86
Correction: Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies 86
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia 85
Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol 84
Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia 83
Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis 82
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 82
Mitochondria and Alzheimer's disease. 81
Novel presenilin 1 mutation (Ile408Thr) in an Italian family with late-onset Alzheimer's disease 81
No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients 79
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 78
Epigenetic modifications in Alzheimer's disease: Cause or effect? 78
CXCR4 involvement in neurodegenerative diseases 75
Frontotemporal dementia and its subtypes: a genome-wide association study 75
"stato dell'arte" della ricerca 73
Cholesteryl ester transfer protein (CETP) I405V polymorphism in Italian memory complainers 72
Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases 69
Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease 65
Incomplete penetrance in familial Alzheimer’s disease with PSEN1 Ala260Gly mutation 63
C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts 62
Implication of a genetic variant at PICALM in Alzheimer’s disease patients and centenarians 60
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 57
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 55
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 47
Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes 45
Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia 43
Totale 7.654
Categoria #
all - tutte 21.593
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.593


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.161 0 0 0 0 173 197 224 181 163 96 96 31
2020/2021780 74 78 69 111 29 55 32 69 65 116 43 39
2021/2022521 16 30 50 22 13 28 16 42 27 22 92 163
2022/20231.288 136 307 47 120 68 213 167 58 125 9 25 13
2023/2024759 30 52 75 26 32 69 25 334 10 42 45 19
2024/20251.814 87 334 220 476 697 0 0 0 0 0 0 0
Totale 7.654